Herbert Virgin Net Worth & Insider Trades

Herbert Virgin - EVP, Vir Biotechnology, Inc

As of March 11, 2022

What is Herbert Virgin's Net Worth?

The current estimated net worth of Vir Biotechnology, Inc's EVP, Herbert Virgin, is estimated to be about $16.29M . Herbert Virgin owns about 175,407 units of Vir Biotechnology, Inc common stock. In the last 2 years at Vir Biotechnology, Inc, Herbert Virgin has sold an estimated value of $11.69M worth.

What is Herbert Virgin's Past Insider Trading?

Herbert Virgin's largest purchase order was 31,300 units , worth over $47.89K on January 27, 2021. Herbert Virgin's largest sale order was 31,300 units , worth over $1.51M on January 27, 2021. In total, Herbert Virgin has made about 64 transactions over 2 years of their time at Vir Biotechnology, Inc. Herbert Virgin usually trades in June, December and September, with the busiest year in 2021. The most recent transaction was a sale order of 1,375 units , worth over $41.25K on February 24, 2022.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was Herbert Virgin's Salary in 2020?

As EVP of Vir Biotechnology, Inc, Herbert Virgin has a total base salary of $636,525 . Herbert Virgin received compensation valued at about $1,106,236 in 2020 after becoming EVP. The vast majority of their compensation came in the form of other earnings, plans or compensations of $374,311 , and other compensation of $95,400 .

What is Herbert Virgin's' Mailing Address?

  • Mailing address is C/o Vir Biotechnology, Inc. 499 Illinois Street, Suite 500 San Francisco CA 94158 CA

Vir Biotechnology, Inc Executive Compensation

Name
Year
Salary
Bonus
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
George Scangos, Ph.D. 2020 $544,583 - - $438,900 $11,400 $994,883
George Scangos, Ph.D. 2019 $514,583 - $3,158,780 $260,044 $11,200 $3,944,607
George Scangos, Ph.D. 2018 $512,019 - - $260,000 $11,000 $783,019
Howard Horn 2020 $444,333 - $960,186 $226,100 $11,400 $1,642,019
Howard Horn 2019 $413,333 - $1,614,687 $174,720 $11,200 $2,213,940
Steven Rice 2020 $441,667 - $1,476,236 $256,956 - $2,174,859
Herbert (“Skip”) Virgin, M.D., Ph.D. 2020 $636,525 - - $374,311 $95,400 $1,106,236
Herbert (“Skip”) Virgin, M.D., Ph.D. 2019 $617,500 - $1,018,963 $248,400 $84,000 $1,968,863
Herbert (“Skip”) Virgin, M.D., Ph.D. 2018 $592,308 $600,000 $627,750 $259,000 $84,000 $2,163,058
Michael Kamarck, Ph.D. 2020 $426,400 - - $266,000 $111,400 $803,800
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1706431/000119312521107570/d318415ddef14a.htm

What are Vir Biotechnology, Inc's Past Insider Trades?

Vir Biotechnology, Inc's most recent insider trade came on July 21, 2022 by Phillip Pang who sold 5,000 units worth $150K . In the last 19 years, insiders at Vir Biotechnology, Inc have sold an estimated value of $78.82M and bought an estimated value of $148.58M worth of shares. Insider trading is most common in June, with the busiest year in 2021. The most active traders at the company are Herbert Virgin, EVP,  Phillip Pang, Chief Medical Officer,  and Vicki Sato, Director .

Vir Biotechnology, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1